GLAND.BO
Gland Pharma Limited$2,268.00
Jun 10, 2026
Market cap
$385.35B
52w range
—
P / E
—
EPS · FY 2026
$62.28
Volume
—
Revenue · FY 2026
$64.31B
Explain this page
Arphra AIPlain-English read on Gland Pharma Limited’s valuationFair value→
—
no model yet
Quant→
—
no factors yet
Trend→
—
regime
Street→
—
no targets
AI Issuer Brief
Arphra AILoading cached brief…
Fair value
Football field →Weighted blend
$1,176.49
— vs spot
Recommendation
n/a
4 of 4 methods
Method spread
0bull0bear
±5% threshold
Insider · 30d
History →Bought
$0
0 txns
Sold
$0
0 txns
Net flow
+$0
Recent quarters
All financials →| Period | Revenue | Net income | EPS |
|---|
Sector & industry today
LiveSectors
- Basic Materials+2.94%
- Industrials+2.57%
- Technology+2.09%
- Consumer Cyclical+1.53%
- Utilities+1.19%
- Healthcare+0.85%
- Financial Services+0.48%
- Communication Services-0.41%
- Real Estate-0.49%
- Consumer Defensive-0.59%
- Energy-2.78%
Top industries (issuer's industry highlighted)
- Drug Manufacturers - General+1.42%
- Travel Services+7.28%
- Copper+6.43%
- Silver+6.40%
- Leisure+6.11%
- Solar+6.09%
- Other Precious Metals+5.40%
- Manufacturing - Metal Fabrication+5.39%
- Electronic Gaming & Multimedia+5.39%
- Airlines, Airports & Air Services+5.14%
- Computer Hardware+5.11%
- Department Stores+5.04%
Analyst view
Consensus target
—
No price-target data returned for this ticker.
Recent actions
0 ↑0 ↓0 hold
- No recent grade actions.
News
DB · news_itemsNo recent news for GLAND.BO.
Peers
No peer list available for GLAND.BO.
Total assets
$125.11B
Total debt
$2.84B
Cash & equiv
$33.59B
Operating CF
$12.31B
Free cash flow
$7.41B
Buybacks
$0
Recent insiders
All →| Insider | Action | Shares | Value | Date |
|---|---|---|---|---|
| No open-market insider activity in the recent window. | ||||
Income statement · annual
5y| Period | Revenue | Op income | Net income | EPS | Net margin |
|---|---|---|---|---|---|
| FY 2026 | $64.31B | $12.06B | $10.27B | $62.28 | +15.98% |